The decision comes one day after an advisory panel voted 15-0 to recommend clearing another step for a potential second option for the youth population. A week before, an FDA panel voted 22-0 June 14 recommending Moderna’s vaccine for children as young as 6.
Both Pfizer and Moderna’s vaccines are authorized nationally for Americans as young as 6 months old.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
